Publications by authors named "B P Mwipatayi"
A rare case of infectious aortitis caused by Burkholderia pseudomallei.
Int J Surg Case Rep
December 2024
Introduction: Melioidosis is caused by Burkholderia pseudomallei and primarily affects non-vascular organ systems. We present a case of a melioidotic penetrating aortic ulcer (PAU) with unusual clinical features of vascular infection. The patient was successfully treated with a single-stage neoaortoiliac system procedure, highlighting the challenges in managing melioidotic aortic infections.
View Article and Find Full Text PDFArticle Synopsis
- This study aimed to evaluate the mid-term results of drug-coated balloons (DCBs) in treating infrainguinal peripheral arterial disease (PAD) in patients with dyslipidemia compared to those without.
- It analyzed data from 876 patients involved in the BIOLUX P-III study and found no differences in major adverse events but noted that patients with dyslipidemia had significantly higher rates of clinically driven target lesion revascularization (CD-TLR) and target vessel revascularization (TVR) at 6, 12, and 24 months.
- The findings suggest that while dyslipidemia does not affect overall safety outcomes, it may lead to less favorable revascularization results when treated with Passeo
The BIO REACT study is designed to investigate the incremental value of Extravascular UltraSound (EVUS) added to conventional angiography, compared to conventional angiography only for the identification of Flow-Limiting Dissections (FLD) and to evaluate the safety and efficacy of the REsponse Adapted Combination Therapy (REACT) for the treatment of femoropopliteal lesions. The primary endpoints were the specificity and sensitivity of EVUS added to angiography for the detection of FLD. Secondary endpoints were primary patency of the REACT therapy within 12 months, fCD-TLR, freedom from MAE, major target limb amputations (mTLA) and survival rates within 24 months.
View Article and Find Full Text PDFObjectives: The aim of this study was to evaluate the impact of sex on mid-term outcomes following stenting for aorto-iliac occlusive disease (AIOD).
Methods: The Covered versus Balloon Expandable Stent Trial (COBEST) compared the safety and efficacy of the covered stent (CS) with those of the bare metal stent (BMS) in the treatment of hemodynamically significant AIOD. It was identified that CS provided a significant benefit.
Results from the First-in-Human Study of the Caterpillar™ Arterial Embolization System.
Cardiovasc Intervent Radiol
January 2023
Purpose: To assess occlusion success and adverse events associated with the use of a self-expanding device for peripheral artery embolization.
Methods: This prospective, single-arm, feasibility study was conducted using the Caterpillar™ Arterial Embolization Device composed of opposing nitinol fibers and a flow-occluding membrane. Twenty patients (24 embolization sites) were treated at four investigational centers in New Zealand and Australia and followed for 30 days.